Marta Tapia

4PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersMolecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 01, 2025
Associations of the HER2DX Genomic Test with Biological and Pathologic Features in HER2-Positive Breast Cancer.

Esther Sanfeliu, Anabel Martínez-Romero, Mercedes Marín-Aguilera

|Nov 11, 2022
Role of SALL4 in HER2+ Breast Cancer Progression: Regulating PI3K/AKT Pathway.

Birlipta Pattanayak, Ana Lameirinhas, Sandra Torres-Ruiz

|Jul 09, 2022
Immunological Landscape of HER-2 Positive Breast Cancer.

Santiago Moragon, Cristina Hernando, Maria Teresa Martinez-Martinez

|Aug 07, 2021
Oral Selective Estrogen Receptor Degraders (SERDs) as a Novel Breast Cancer Therapy: Present and Future from a Clinical Perspective.

Cristina Hernando, Belén Ortega-Morillo, Marta Tapia

Pageof 1

Frequent Collaborators

3 joint publications

Juan Miguel Cejalvo

2 joint publications

Pilar Eroles

1 joint publications

Cristina Hernando

1 joint publications

Belén Ortega-Morillo